Assessment Of Thyroid Stimulating Hormone, Triiodothyronine, Luteinizing Hormone And Follicle-Stimulating Hormone Levels in Polycystic Ovary Syndrome
DOI:
https://doi.org/10.46966/msjar.v5i1.155Keywords:
Polycystic ovary syndrome, Thyroid hormones (TSH and T3, Luteinizing hormone (LH),, Follicle stimulating hormone (FSH).Abstract
Bachgraund: Polycystic ovarian syndrome (PCOS) is the most prevalent endocrinopathy and reproductive condition with hyperandrogenism that affects young women of reproductive age., It is a disorder with many distinct faces that affects millions of women worldwide, and it causes them considerable emotional and physical suffering. The present study is designed to estimate the TSH, T3, LH, and FSH levels in women with polycystic ovarian syndrome (PCOS). The blood samples were collected from 60 females, 30 control, and 30 patients. A device named VIDAS was used to measure TSH, T3 LH, and FSH. The present results indicated that levels of TSH, LH, and FSH were elevated (P<0.05) significantly in the patient's group, while serum levels of Triiodothyronine decreased in the PCOS females group. According to the results of the current study, PCOS patients had hypothyroidism, which was demonstrated by elevated TSH, LH, and FSH levels.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Doaa AbdAlzahra Deli
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
